←
Tamara Lotan, MD50 posts
Tamara Lotan, MD avatar

Tamara Lotan, MD

@LotanLab

Molecular pathologist with focus on prostate cancer. Johns Hopkins University.

◷ Joined May 2019
Kaushal Asrani avatar
⟳ Tamara Lotan, MD retweeted
Kaushal Asrani@AsraniKaushal·16 Oct 2025

Excited to finally share our latest study on #TranslocationRCC #PEComas @NatureComms! We generated the first ever, murine transgenic kidney tumor models of SFPQ-TFE3 - the most common MiT/TFE gene fusion implicated in both, tRCC and PEComas (Perivascular Epitheloid neoplasms). We describe a novel role for this fusion in regulating #mTORC1-driven lineage plasticity, with transcriptional downregulation of critical nephric lineage transcription factors like PAX8, that perfectly recapitulate human renal PEComas. Additionally, we nominate the lysosomal V-ATPase complex as a central regulator of mTORC1 activity in tRCC, and a target-rich environment for therapeutic intervention in this deadly disease. Grateful to all the co-authors, collaborators, reviewers, editors and funding sources who made this study possible! @adriannaamendes @LotanLab @eddieimada @MasayaBaba2 @terry_watnickmd @WMarstonLinehan @PeterArgani @yasserged @rmelias2 @nirmishsingla @allaf_mo @Joeyswings @KidneyCancer @kidneycan @CDMRP nature.com/articles/s41467-0…

Post attachment
Ralph Hruban avatar
⟳ Tamara Lotan, MD retweeted
Ralph Hruban@RalphHruban·23 Mar 2025

Congratulations Johns Hopkins resident Eric Young- winner of the 2025 abstract award from the Pancreatobiliary Society at the 2025 USCAP meetings!

Post attachment
Samson W. Fine, MD avatar
⟳ Tamara Lotan, MD retweeted
Samson W. Fine, MD@rovingatuscap·6 Mar 2025

GUPS @GU_Path_Society Poster Walks return for #USCAP2025 featuring an outstanding line-up of international experts in #gupath Especially geared to trainees, Poster Walk leaders will provide context, thematic discussion, and curated knowledge to enhance your learning experience!

Post attachment
Denis Wirtz avatar
⟳ Tamara Lotan, MD retweeted
Denis Wirtz@deniswirtz·17 Dec 2024

Hopkins is recruiting 30 Bloomberg Distinguished Professors in AI + X (X = astrophysics, cancer, neuroscience, genomics, social sciences, etc.) hub.jhu.edu/2024/12/17/data-… 22 of these 30 will be organized in clusters:

Post attachment
Joey's Wings Foundation avatar
⟳ Tamara Lotan, MD retweeted
Joey's Wings Foundation@Joeyswings·16 Oct 2024

Trailblazer Award – $75,000 in partnership with @KidneyCancer was granted to Dr. Kaushal Asrani of Johns Hopkins University School of Medicine! This research project: Therapeutic Targeting of EGFR and HER2 in Translocation Renal Cell Carcinoma.

Post attachment
dahlia kurtz ✡︎ דליה קורץ avatar
⟳ Tamara Lotan, MD retweeted
dahlia kurtz ✡︎ דליה קורץ@DahliaKurtz·5 Oct 2024

This is October 7. And you must bear witness. The KiIIing Roads is a raw documentary of that Black Saturday — with about 50% of never-before-seen-footage. Yes. This will punch you in your heart — over and over. The filmmaker Igal Hecht has made it free for all. Please share.

1:54:48
Kaushal Asrani avatar
⟳ Tamara Lotan, MD retweeted
Kaushal Asrani@AsraniKaushal·19 Jul 2024

Excited to share our joint review with @NicolaAlesi @LisaHenske @LotanLab on the ever-expanding role of the MiT/TFE factors as upstream activators of mTORC1 and drivers of renal tumorigenesis #TSC #BHD #tRCC #TFEopathies #mTOR

#ArticlesInPress: "The Spectrum of "TFEopathies" - Flipping the mTOR Switch in Renal Tumorigenesis" by Alesi et al. ow.ly/bA2e50SE867

Post attachment
Scott Eggener avatar
⟳ Tamara Lotan, MD retweeted
Scott Eggener@uroegg·23 Jun 2024

Hard to imagine a future without AI pathology: - outperforms high-quality pathologists - provides the % of Gleason pattern 3, 4, and 5 Predicting prostate cancer grade reclassification on active surveillance using a deep Learning-Based grading algorithm academic.oup.com/jnci/articl…

International Society of Urological Pathology avatar
⟳ Tamara Lotan, MD retweeted
International Society of Urological Pathology@IntSocUropath·10 Jun 2024

Join the #ISUP “Consensus Conference on GU Precursor Lesions,” open to all in pathology, urology, and oncology. #ISUPItaly2024 🇮🇹 Complete the pre-meeting survey from all 5️⃣ working groups. Your input matters! 🔗: surveymonkey.com/r/BPNZ65X 🗳️ Voting Period Ends: June 30

#ISUP Upcoming Event 2024 ISUP Italy Multidisciplinary Consensus Conference on Precursor Lesions of Genitourinary Organs #ISUPItaly2024 🇮🇹 📅 12 Sept 2024, immediately following @ESP_Pathology #ECPItaly2024 Register here: ISUP-ITALY-2024.eventbrite.c…

Post attachment